Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Alogliptin / pioglitazone Tablet bulk supplier for pharma manufacturers

Alogliptin / Pioglitazone Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 12.5 mg / 30 mg, 25 mg / 15 mg, 25 mg / 30 mg, 25 mg / 45 mg

Reference Brands: Oseni (USA), Incresync(EU)

Category: Diabetes

Alogliptin/pioglitazone is an oral medication for type 2 diabetes mellitus. It combines alogliptin, a DPP-4 inhibitor, and pioglitazone, a thiazolidinedione, to help control blood sugar levels. The combination improves insulin response and reduces liver glucose production. Taken once daily, it is used when diet, exercise, or single-drug therapy is insufficient.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Alogliptin / Pioglitazone is a fixed-dose combination anti-diabetic medication designed to improve glycemic control in adults with type 2 diabetes mellitus (T2D). Type 2 diabetes is a progressive condition that often requires sequential additions of therapy to maintain blood glucose levels. By combining two complementary mechanisms of action, this combination provides an effective and convenient treatment option. Alogliptin, a dipeptidyl peptidase-4 (DPP‑4) inhibitor, increases incretin activity, enhancing insulin release and suppressing glucagon secretion in a glucose-dependent manner. Pioglitazone, a thiazolidinedione, improves insulin sensitivity in peripheral tissues, helping to lower blood glucose and support long-term glycemic control.

Fixed-dose combinations like Alogliptin / Pioglitazone simplify therapy regimens, which can enhance medication adherence and improve patient outcomes. The combination is marketed globally under brand names such as Oseni and Incresync. Use of this therapy should be guided by individual patient needs, considering factors such as renal function, cardiovascular status, and potential adverse effects. Regular monitoring and collaboration with healthcare professionals ensure safe and effective management of type 2 diabetes with this combination therapy.

Alogliptin / Pioglitazone Tablet — third party manufacturing & bulk supply

Alogliptin / Pioglitazone Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Alogliptin / Pioglitazone Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Alogliptin / Pioglitazone Tablet →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Alogliptin / Pioglitazone is used to improve glycemic control in adults with type 2 diabetes mellitus. Alogliptin increases incretin activity to enhance insulin release and suppress glucagon levels, while pioglitazone improves insulin sensitivity in peripheral tissues, helping to lower blood glucose levels when diet and exercise alone are not sufficient.

This combination contains two active ingredients: alogliptin benzoate, a dipeptidyl peptidase‑4 (DPP‑4) inhibitor, and pioglitazone hydrochloride, a thiazolidinedione that increases insulin sensitivity.

The combination product is marketed under brand names such as Oseni and Incresync in various regions.

It is manufactured by multiple pharmaceutical companies globally, including generic manufacturers approved in different countries.

The generic name is alogliptin and pioglitazone.

Common brand names include Oseni and Incresync.

Alogliptin / Pioglitazone is manufactured in several countries, including India, the USA, and European nations, by approved pharmaceutical manufacturers.

Related Products

Repaglinide

Strength:
0.5 mg, 1 mg, 2 mg

Form: Tablets

Reference Brands: Prandin (USA)

View Details
Pioglitazone Hydrochloride 150Mg Tablet

Strength:
15 mg, 30 mg, 45 mg

Form: Tablets

Reference Brands: Actos (USA)

View Details
Nateglinide

Strength:
60 mg, 120 mg, 180 mg

Form: Tablets

Reference Brands: Starlix (USA)

View Details
Miglitol

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Glyset (USA), Diastabol (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.